The role of histopathology in the evaluation of risk of lung cancer from environmental tobacco smoke

Current clinical practice for treating lung cancer does not provide adequate histopathological evaluation for the clear distinction between primary and metastatic neoplasia. Reliance on such clinical diagnosis jeopardises the scientific validity of many epidemiological studies designed to assess the risk of inhalation of environmental tobacco smoke (ETS).